REVIEW 3 major objections 5 minor 66 references
MolecularCanvas: LLM-assisted Small-Molecule Drug Discovery via Structure-Guided Constraints
T0 review · 3 major / 5 minor · reviewed 2026-08-05 · deepseek-v4-flash
Pith's one-line read MolecularCanvas claims that letting chemists annotate molecules directly on a canvas makes LLM-assisted drug optimization more effective, with expert-rated final molecules beating a familiar-tool baseline.
desk verdict The system design is thoughtful and the qualitative findings are plausible, but the paired user study is confounded by task, so the headline quantitative claims don't stand as reported. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
The load-bearing mechanism is the structured optimization context plus a two-stage generation pipeline. The context is a formal specification that captures the current molecule in SMILES, a text goal, property constraints with target ranges, and atom-resolved structural annotations (anchor/avoid/free-form) taken directly from the Ketcher molecular editor, without vision-language parsing. The pipeline first asks an LLM to propose an edit plan as discrete operations, then runs those operations through RDKit to generate concrete molecules, checks chemical validity, removes duplicates and near-duplicates by Morgan fingerprint similarity (Tanimoto >0.85), scores candidates on property satisfactio
What would settle it
A matched controlled experiment would settle it: same LLM, same property calculators, same evidence database, and only the input modality varied (structured canvas annotations vs. plain text prompts), with chemists randomly assigned and unaware of the hypothesis. If expert-rated final-molecule quality, structural-constraint satisfaction, and SUS scores are not higher in the structured condition, the central claim fails. A cheaper log-based check: track whether anchor/avoid constraints are ever violated by top-ranked candidates in the current system; if violations are rare even in text-only bas
Extended reading notes
Core claim
At the center of the paper is a proposed fix for a workflow mismatch: chemists think in molecular structures, but generative AI tools mostly accept language. MolecularCanvas lets users select atoms and bonds on a 2D canvas and tag them as anchor (preserve), avoid (do not touch), or free-form instructions, combine this with desired property ranges and reference molecules, and feed the whole structured package to an LLM. The LLM is asked to produce an explicit edit plan of executable operations—replace atom X with fluorine, add a polar group at position Y—rather than a finished molecule, and RDKit executes and validates the plan. The paper's claim is that this structured, evidence-backed, inte
Load-bearing premise
The load-bearing premise is that the baseline—each participant using whatever familiar tools they chose—is a fair comparator, so the measured gains reflect MolecularCanvas's design rather than unequal familiarity, tutorial exposure, or a novelty effect.
Editorial extensions
If this is right
- Chemists can specify precise modifications—keep this ring, replace this chloride with fluorine—by pointing at the molecule, removing the need to translate structural intent into prompt prose.
- Candidates arrive with provenance (known compounds, safety signals, clinical phase, patents), so users can judge and justify AI suggestions in collaborative settings.
- Branching history lets users revert, compare, and pursue multiple design directions, turning optimization from a linear sequence into an explorable graph.
- Because the LLM only proposes edit plans and RDKit executes them, invalid or duplicate molecules are filtered before display; logs suggest roughly one valid, non-duplicate, constraint-satisfying candidate per two generation attempts.
- Integrating property calculators and evidence lookup into one interface removes the repeated switching between separate generation, property, and visualization tools that participants described.
Reading between the lines
- The same structure-as-interface pattern should transfer to other structure-intensive domains—protein engineering, materials discovery, reaction planning—where users can point at the object to constrain generation; the authors gesture at this but do not test it.
- The reported gains may partly reflect novelty and tutorial warm-up rather than the interface alone; a component-level ablation would show whether anchor/avoid annotations, property sliders, or evidence cards each contribute independently.
- The History Panel plus logged annotations is effectively an auto-generated design notebook; if it records decisions and evidence, it could make molecular optimization audits and reproducibility checks far cheaper than manual note-taking.
- The edit-plan architecture is a reusable safety layer for LLM chemistry tools: restricting the model to executable operations and validating them deterministically bounds hallucination in a way that free-form molecule generation does not.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. MolecularCanvas is an interactive system for LLM-assisted small-molecule optimization. It lets users specify high-level goals, structure-level annotations (anchor/avoid/free-form), property targets, and reference-based preferences; these are compiled into a structured intent representation, used to generate an explicit RDKit-executable edit plan, and candidates are validated, ranked, and presented with supporting evidence from ChEMBL/PubChem. The paper reports a formative study with six experts that yields five design requirements, the system design, and a user study with 12 participants in which MolecularCanvas is claimed to outperform a baseline on all 13 perceived-effectiveness items, SUS (72.5 vs. 60.8), and expert-rated final molecule quality (0.73 vs. 0.58). The authors also report pipeline reliability logs (95% executable edit plans, 57% valid candidates after filtering, 91% constraint satisfaction).
Significance. If the effectiveness claim were well supported, the paper would make a useful contribution: it addresses a real gap in generative molecular design tools by making structure-level intent explicit, providing evidence provenance, and integrating evaluation tools into one environment. The structured intent formalism and the two-stage edit-plan generation are sensible and reusable ideas, and the pipeline reliability logs are a valuable empirical addition. The formative study is appropriate for deriving design requirements. The main weakness is that the user-study evidence, which is load-bearing for the central claim, is confounded by the assignment of different tasks to the two conditions and by an uncontrolled baseline; the current data do not cleanly isolate the system effect.
major comments (3)
- [§5.1.4 / §5.2.1] The central effectiveness claim rests on a comparison that confounds system with task. Each participant used one system on Task A (nalidixic acid → quinolone) and the other system on Task B (cefazolin → cephalosporin), with only the order counterbalanced. The two tasks differ in starting molecule, optimization goal, and constraint complexity. Thus each paired difference on Q1–Q13, SUS, and expert ratings is a difference across two different tasks, not a difference between systems on the same task. If one task is intrinsically easier or more satisfying, the observed superiority of MolecularCanvas could arise from task assignment even with no true system benefit. The paper does not report per-task means or include task as a factor in any analysis. To support the claim, the authors must provide per-task descriptive statistics and either (a) compare systems within each task using the appropr
- [§5.1.2] The baseline condition is not a fixed comparator: 'participants were allowed to use any tools they were familiar with in the baseline conditions.' These tools vary per participant (different conversational AI, property calculators, editors), and the paper reports no measure of prior familiarity or fluency with the baseline tools or with MolecularCanvas after the tutorial. A participant who is less skilled with their self-selected baseline may rate it lower for reasons unrelated to MolecularCanvas, and a novelty or tutorial effect could inflate the test condition. The authors should either use a matched alternative interface or, at minimum, measure and statistically control for tool familiarity and prior experience, and report the robustness of the results under such controls.
- [§5.2.1] The quantitative analysis reports p-values for 13 questionnaire items and the SUS without multiple-comparison correction and without effect sizes or confidence intervals. With n=12 and a large number of significance tests, the reported 'all p<0.05' pattern is difficult to interpret. The authors should report exact test statistics (e.g., Wilcoxon W or t-value), effect sizes (e.g., rank-biserial or Cliff's delta), and either apply a correction or explicitly justify why it is unnecessary. This is also needed to help readers evaluate the magnitude of the perceived differences, which appear substantial on several items but are not quantified beyond means and standard deviations.
minor comments (5)
- [§4.3.2/§4.3.3] Near-duplicate removal uses Tanimoto similarity >0.85 and evidence retrieval uses ≥0.8, but these thresholds are not justified or varied in sensitivity analysis. Since they are free parameters of the pipeline, a brief rationale or robustness check would strengthen the presentation.
- [§5.2.1] The paper states 'Wilcoxon signed-rank test, p<0.001' for expert ratings and 'Wilcoxon p<0.05' for SUS, but the questionnaire items do not state which test was used. Please specify the test and whether it was paired or otherwise, and clarify how ties in Likert ratings were handled.
- [§5.1.4 / Figure 3] Figure 3 shows paired distributions for Q1–Q13, but individual-level paired data would be more informative, especially for judging the consistency and direction of the differences. Consider adding a paired-by-participant visualization or data table in the supplementary.
- [§5.2.1] The generation reliability numbers (95% executable plans, 57% valid candidates, 91% constraint satisfaction) are useful, but the 57% is the fraction passing validity and diversity filtering; the paper should state the base number of attempts and the number of candidates actually presented to users, so readers can gauge the practical user-facing yield.
- [§6.2] The limitations section is honest about missing ablations, but a sentence in Section 5.2.1 or Section 6 could note that the user study does not establish which components (e.g., anchor/avoid annotations, evidence panels, integrated property views) drive the observed differences. This would help set expectations for future work.
Circularity Check
No significant circularity: MolecularCanvas is an empirical HCI systems evaluation; its effectiveness claim rests on a user study and external expert ratings, not on a self-derivation or fitted prediction.
full rationale
This is a systems paper, not a derivation. The central claim that MolecularCanvas improves molecular optimization outcomes is supported by a paired user study with 12 participants (Section 5.1.4) and by independent expert ratings of final molecules (Section 5.2.1: 'the molecules generated with MolecularCanvas received higher ratings than those from the baseline (mean 0.73 for MolecularCanvas vs. 0.58 for the baseline...)' with the expert evaluation anonymized and presented in random order). The computational pipeline (Section 4.3) is a prompt-and-validate pipeline around GPT-4o and RDKit; it fits no parameters to a target result and then re-presents that fit as a prediction. The reported generation reliability rates (95.0% executable edit plans, 57.0% validity/diversity pass, 91.0% structural-constraint satisfaction) are self-consistency checks on the generator, not claims that those same internally computed constraint scores independently validate the system's usefulness. The paper's few self-citations ([42], [43], [44], [47], [49], [56]) occur in related-work and future-work contexts and are not load-bearing for the main effectiveness claim. The strongest validity concerns are not circularity: the baseline was uncontrolled ('participants were allowed to use any tools they were familiar with in the baseline conditions', Section 5.1.2), and the two formal tasks were paired with the two systems in counterbalanced order (Section 5.1.4), so task difficulty may be confounded with system. Such a confound is an internal-validity limitation, not an equivalence-by-construction between conclusion and input. The paper's own limitation section honestly states that no component-level ablation was conducted (Section 6.2: 'We did not conduct a component-level ablation study...'), which acknowledges missing evidence rather than disguising a circular step. Overall, no step in the paper's argument reduces to its own inputs by definition, fitting, or self-citation chain.
Assumptions & free parameters
free parameters (4)
- Near-duplicate Tanimoto threshold =
0.85
- Evidence similarity threshold =
0.8
- Top-k candidate selection k =
not specified
- Candidate scoring weights =
not specified
assumptions (4)
- domain assumption GPT-4o can produce executable edit plans from structured molecular intent
- domain assumption RDKit can faithfully execute the specified edit operations while preserving intended structure
- domain assumption Property predictions from integrated computational tools are accurate enough for optimization decisions
- domain assumption Self-reported ratings and two expert quality judgments are valid proxies for real-world molecular optimization success
Cite this review
Pith. "Pith review of MolecularCanvas: LLM-assisted Small-Molecule Drug Discovery via Structure-Guided Constraints." pith.science (2026). https://pith.science/paper/HYHIEO3X
@misc{pith2026260800393,
author = {Pith},
title = {Pith review of: MolecularCanvas: LLM-assisted Small-Molecule Drug Discovery via Structure-Guided Constraints},
year = {2026},
howpublished = {\url{https://pith.science/paper/HYHIEO3X}},
note = {Machine review of arXiv:2608.00393}
}
read the original abstract
Small-molecule drug discovery relies on iterative molecular optimization, where chemists repeatedly modify candidate compounds to balance multiple competing properties such as efficacy, toxicity, and solubility. Recent advances in generative AI (GenAI) have shown promise in accelerating this process by automatically proposing new molecular structures or targeted modifications. However, existing GenAI-based molecular design tools remain poorly aligned with experts' real-world workflows. Specifically, they offer limited support for specifying structure-level modification intents on molecules, provide insufficient transparency into model-generated modifications, and lack integrated support for downstream property evaluation with external computational tools. To address these challenges, we introduce MolecularCanvas, an interactive system that enables users to iteratively construct an optimization context by integrating high-level goals, structure-level annotations, property constraints, and reference-based preferences. This context guides the generation of candidate molecules across diverse molecular structures. MolecularCanvas further enhances transparency by providing evidence for AI-generated suggestions and streamlines molecular evaluation by integrating commonly used computational tools for property assessment into a unified interface. Finally, a user study with 12 participants demonstrates the usefulness and effectiveness of MolecularCanvas in helping users optimize candidate molecules.
Figures
Reference graph
Works this paper leans on
-
[1]
Ian Arawjo, Chelse Swoopes, Priyan Vaithilingam, Martin Wattenberg, and Elena L. Glassman. 2024. ChainForge: A Visual Toolkit for Prompt Engineer- ing and LLM Hypothesis Testing. InProceedings of the 2024 CHI Conference on Human Factors in Computing Systems(Honolulu, HI, USA)(CHI ’24). Asso- ciation for Computing Machinery, New York, NY, USA, Article 304,...
arXiv 2024
-
[2]
Hartmut Beck, Michael Härter, Bastian Haß, Carsten Schmeck, and Lars Baer- facker. 2022. Small Molecules and Their Impact in Drug Discovery: A Perspective on the Occasion of the 125th Anniversary of the Bayer Chemical Research Labo- ratory.Drug Discovery Today27, 6 (2022), 1560–1574. doi:10.1016/j.drudis.2022. 02.015
-
[3]
Luca Beurer-Kellner, Marc Fischer, and Martin Vechev. 2023. Prompting Is Pro- gramming: A Query Language for Large Language Models.Proc. ACM Program. Lang.7, PLDI, Article 186 (June 2023), 24 pages. doi:10.1145/3591300
doi:10.1145/3591300 2023
-
[4]
G. Richard Bickerton, Gaia V. Paolini, Jérémy Besnard, Sorel Muresan, and An- drew L. Hopkins. 2012. Quantifying the Chemical Beauty of Drugs.Nature Chemistry4, 2 (2012), 90–98. doi:10.1038/nchem.1243
-
[5]
Andres M Bran, Sam Cox, Oliver Schilter, Carlo Baldassari, Andrew D White, and Philippe Schwaller. 2024. Augmenting Large Language Models with Chemistry Tools.Nature Machine Intelligence6, 5 (2024), 525–535. doi:10.1038/s42256-024- 00832-8
-
[6]
John Brooke. 1996. SUS: A “Quick and Dirty” Usability Scale. InUsability Evalu- ation in Industry, Patrick W. Jordan, Bruce Thomas, Bernard A. Weerdmeester, and Ian L. McClelland (Eds.). Taylor & Francis, London, 189–194
work page 1996
-
[7]
Tom Brown, Benjamin Mann, Nick Ryder, Melanie Subbiah, Jared D Kaplan, Prafulla Dhariwal, Arvind Neelakantan, Pranav Shyam, Girish Sastry, Amanda Askell, Sandhini Agarwal, Ariel Herbert-Voss, Gretchen Krueger, Tom Henighan, Rewon Child, Aditya Ramesh, Daniel Ziegler, Jeffrey Wu, Clemens Winter, Chris Hesse, Mark Chen, Eric Sigler, Mateusz Litwin, Scott Gr...
arXiv 2020
-
[8]
Zixin Chen, Yuhang Zeng, Sicheng Song, Yanna Lin, Xian Xu, Huamin Qu, and Meng Xia. 2026. VizQStudio: Iterative Visualization Literacy MCQs Design With Simulated Students.IEEE Transactions on Visualization and Computer Graphics 32, 8 (2026), 7468–7485. doi:10.1109/TVCG.2026.3695959
Show all 66 references
-
[9]
DaEun Choi, Sumin Hong, Jeongeon Park, John Joon Young Chung, and Juho Kim
-
[10]
John Joon Young Chung and Eytan Adar. 2023. PromptPaint: Steering Text- to-Image Generation Through Paint Medium-like Interactions. InProceedings of the 36th Annual ACM Symposium on User Interface Software and Technology. Association for Computing Machinery, New York, NY, USA,...
2023
-
[11]
Antoine Daina, Olivier Michielin, and Vincent Zoete. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.Scientific Reports7, 1 (2017), 42717. doi:10.1038/ srep42717
2017
-
[12]
Carl Edwards, Tuan Lai, Kevin Ros, Garrett Honke, Kyunghyun Cho, and Heng Ji. 2022. Translation between Molecules and Natural Language. InProceedings of the 2022 Conference on Empirical Methods in Natural Language Processing. Association for Computational Linguistics, Abu Dhab...
2022 doi
-
[13]
EPAM Systems. 2024. Ketcher: Open-source Web-based Chemical Structure Editor. https://github.com/epam/ketcher
2024
-
[14]
Wenhao Gao, Tianfan Fu, Jimeng Sun, and Connor Coley. 2022. Sample Efficiency Matters: A Benchmark for Practical Molecular Optimization. InAdvances in Neural Information Processing Systems, Vol. 35. Curran Associates, Inc., Red Hook, NY, USA, 21342–21357. doi:10.52202/068431-1551
2022 doi
-
[15]
Leach, Graeme R
Ed Griffen, Andrew G. Leach, Graeme R. Robb, and Daniel J. Warner. 2011. Matched Molecular Pairs as a Medicinal Chemistry Tool.Journal of Medici- nal Chemistry54, 22 (2011), 7739–7750. doi:10.1021/jm200452d
2011 doi
-
[16]
Hann and György M
Michael M. Hann and György M. Keserü. 2012. Finding the Sweet Spot: the Role of Nature and Nurture in Medicinal Chemistry.Nature Reviews Drug Discovery 11, 5 (2012), 355–365. doi:10.1038/nrd3701
2012 doi
-
[17]
JP Hughes, S Rees, SB Kalindjian, and KL Philpott. 2011. Principles of Early Drug Discovery.British Journal of Pharmacology162, 6 (2011), 1239–1249. doi:10.1111/ j.1476-5381.2010.01127.x
2011
-
[18]
Ross Irwin, Spyridon Dimitriadis, Jiazhen He, and Esben Jannik Bjerrum. 2022. Chemformer: A Pre-trained Transformer for Computational Chemistry.Machine Learning: Science and Technology3, 1 (2022), 015022. doi:10.1088/2632-2153/ac3ffb
2022 doi
-
[19]
Shoichi Ishida, Tomohiro Sato, Teruki Honma, and Kei Terayama. 2025. Large Language Models Open New Way of AI-Assisted Molecule Design for Chemists. Journal of Cheminformatics17, 1 (2025), 36. doi:10.1186/s13321-025-00984-8
2025 doi
-
[20]
Jan H. Jensen. 2019. A Graph-based Genetic Algorithm and Generative Mod- el/Monte Carlo Tree Search for the Exploration of Chemical Space.Chemical Science10 (2019), 3567–3572. doi:10.1039/C8SC05372C
2019 doi
-
[21]
Wengong Jin, Regina Barzilay, and Tommi Jaakkola. 2018. Junction Tree Vari- ational Autoencoder for Molecular Graph Generation. InProceedings of the 35th International Conference on Machine Learning, Vol. 80. PMLR, 2323–2332. https://proceedings.mlr.press/v80/jin18a.html
2018
-
[22]
Hyeonah Kim, Minsu Kim, Sanghyeok Choi, and Jinkyoo Park. 2024. Genetic- guided GFlowNets for Sample Efficient Molecular Optimization. InAdvances in Neural Information Processing Systems. Curran Associates, Inc., Red Hook, NY, USA, 42618–42648. doi:10.52202/079017-1350
2024 doi
-
[23]
Tae Soo Kim, Yoonjoo Lee, Minsuk Chang, and Juho Kim. 2023. Cells, Genera- tors, and Lenses: Design Framework for Object-Oriented Interaction with Large Language Models. InProceedings of the 36th Annual ACM Symposium on User Interface Software and Technology. Association for C...
2023
-
[24]
Diederik P Kingma and Max Welling. 2013. Auto-Encoding Variational Bayes. arXiv:1312.6114 [stat.ML] https://arxiv.org/abs/1312.6114
2013 arXiv
-
[25]
Jordy Homing Lam and Vsevolod Katritch. 2025. Navigating Structure-based Drug Discovery with Emerging Innovations in Physics- and Knowledge-based Approaches.npj Drug Discovery2, 1 (2025), 29. doi:10.1038/s44386-025-00031-4
2025 doi
-
[26]
Greg Landrum et al . 2026. RDKit: Open-Source Cheminformatics Software. Zenodo. doi:10.5281/zenodo.21291217
2026 doi
-
[27]
Yanna Lin, Haotian Li, Leni Yang, Aoyu Wu, and Huamin Qu. 2023. Inksight: Leveraging sketch interaction for documenting chart findings in computational notebooks.IEEE Transactions on Visualization and Computer Graphics30, 1 (2023), 944–954
2023
-
[28]
Christopher A Lipinski, Franco Lombardo, Beryl W Dominy, and Paul J Feeney
-
[29]
Pengfei Liu, Weizhe Yuan, Jinlan Fu, Zhengbao Jiang, Hiroaki Hayashi, and Graham Neubig. 2023. Pre-train, Prompt, and Predict: A Systematic Survey of Prompting Methods in Natural Language Processing.ACM Comput. Surv.55, 9, Article 195 (Jan. 2023), 35 pages. doi:10.1145/3560815
2023 doi
-
[30]
Loeffler, Jiazhen He, Alessandro Tibo, Jon Paul Janet, Alexey Voronov, Lewis H
Hannes H. Loeffler, Jiazhen He, Alessandro Tibo, Jon Paul Janet, Alexey Voronov, Lewis H. Mervin, and Ola Engkvist. 2024. Reinvent 4: Modern AI–driven Generative Molecule Design.Journal of Cheminformatics16, 1 (2024), 20. doi:10.1186/s13321-024-00812-5
2024 doi
-
[31]
Damien Masson, Sylvain Malacria, Géry Casiez, and Daniel Vogel. 2024. Direct- GPT: A Direct Manipulation Interface to Interact with Large Language Models. InProceedings of the 2024 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery, New Y...
2024
-
[32]
Maurer, Martin Edwards, David Hepworth, Patrick Verhoest, and Charlotte M.N
Tristan S. Maurer, Martin Edwards, David Hepworth, Patrick Verhoest, and Charlotte M.N. Allerton. 2022. Designing Small Molecules for Therapeutic Suc- cess: A Contemporary Perspective.Drug Discovery Today27, 2 (2022), 538–546. doi:10.1016/j.drudis.2021.09.017
2022 doi
-
[33]
Janosch Menke, Yasmine Nahal, Esben Jannik Bjerrum, Mikhail Kabeshov, Samuel Kaski, and Ola Engkvist. 2024. Metis: A Python-based User Interface to Collect Expert Feedback for Generative Chemistry Models.Journal of Cheminformatics 16, 1 (2024), 100. doi:10.1186/s13321-024-00892-3
2024 doi
-
[34]
Riza Özçelik, Helena Brinkmann, Emanuele Criscuolo, and Francesca Grisoni
-
[35]
Stephan Pajer, Marc Streit, Thomas Torsney-Weir, Florian Spechtenhauser, Torsten Möller, and Harald Piringer. 2017. WeightLifter: Visual Weight Space Ex- ploration for Multi-Criteria Decision Making.IEEE Transactions on Visualization and Computer Graphics23, 1 (2017), 611–620....
2017
-
[36]
Gillet, Peter Willett, Visakan Kadirkamanathan, Christopher N
George Papadatos, Muhammad Alkarouri, Valerie J. Gillet, Peter Willett, Visakan Kadirkamanathan, Christopher N. Luscombe, Gianpaolo Bravi, Nicola J. Rich- mond, Stephen D. Pickett, Jameed Hussain, John M. Pritchard, Anthony W. J. Cooper, and Simon J. F. Macdonald. 2010. Lead O...
2010
-
[37]
Xiaohan Peng, Janin Koch, and Wendy E. Mackay. 2024. DesignPrompt: Using Multimodal Interaction for Design Exploration with Generative AI. InProceedings of the 2024 ACM Designing Interactive Systems Conference. Association for Com- puting Machinery, New York, NY, USA, 804–818....
2024
-
[38]
Mihalovits, Maximilian Beckers, Nikolas Fechner, Niko- laus Stiefl, Finton Sirockin, William McCoull, Emma Evertsson, Malin Lemurell, Gergely Makara, and György M
Anita Rácz, Levente M. Mihalovits, Maximilian Beckers, Nikolas Fechner, Niko- laus Stiefl, Finton Sirockin, William McCoull, Emma Evertsson, Malin Lemurell, Gergely Makara, and György M. Keserű. 2025. The Changing Landscape of Medicinal Chemistry Optimization.Nature Reviews Dr...
2025 doi
-
[39]
Sadybekov and Vsevolod Katritch
Anastasiia V. Sadybekov and Vsevolod Katritch. 2023. Computational Approaches Streamlining Drug Discovery.Nature616, 7958 (2023), 673–685. doi:10.1038/ s41586-023-05905-z
2023
-
[40]
Jeff Sauro and James R. Lewis. 2016. Chapter 9 - Six enduring controversies in measurement and statistics. InQuantifying the User Experience (Second Edition) (second edition ed.), Jeff Sauro and James R. Lewis (Eds.). Morgan Kaufmann, Boston, 249–276. doi:10.1016/B978-0-12-802...
2016 doi
-
[41]
Vaucher, Vishnu H
Philippe Schwaller, Daniel Probst, Alain C. Vaucher, Vishnu H. Nair, David Kreutter, Teodoro Laino, and Jean-Louis Reymond. 2021. Mapping the Space of Chemical Reactions using Attention-based Neural Networks.Nature Machine Intelligence3, 2 (2021), 144–152. doi:10.1038/s42256-0...
2021 doi
-
[42]
Rui Sheng, Chuhan Shi, Sobhan Lotfi, Shiyi Liu, Adam Perer, Huamin Qu, and Furui Cheng. 2026. Design patterns of human-AI interfaces in health- care.International Journal of Human-Computer Studies209 (2026), 103737. doi:10.1016/j.ijhcs.2026.103737
2026
-
[43]
Rui Sheng, Xingbo Wang, Jiachen Wang, Xiaofu Jin, Zhonghua Sheng, Zhenxing Xu, Suraj Rajendran, Huamin Qu, and Fei Wang. 2026. TrialCompass: Visual Analytics for Enhancing the Eligibility Criteria Design of Clinical Trials.IEEE Transactions on Visualization and Computer Graphi...
2026
-
[44]
Rui Sheng, Leni Yang, Haotian Li, Yan Luo, Ziyang Xu, Zhilan Zhou, David Gotz, and Huamin Qu. 2023. Knowledge Compass: A Question Answering System Guid- ing Students with Follow-Up Question Recommendations. InAdjunct Proceedings of the 36th Annual ACM Symposium on User Interfa...
2023
-
[45]
Shrout and Joseph L
Patrick E. Shrout and Joseph L. Fleiss. 1979. Intraclass correlations: uses in assessing rater reliability.Psychological Bulletin86, 2 (1979), 420–428. doi:10. 1037/0033-2909.86.2.420
1979
-
[46]
Sicheng Song, Yanjie Zhang, Zixin Chen, Huamin Qu, Changbo Wang, and Chenhui Li. 2026. VizDefender: Unmasking Visualization Tampering Through Proactive Localization and Intent Inference.IEEE Transactions on Visualization and Computer Graphics32, 6 (2026), 4720–4730. doi:10.110...
2026
-
[47]
Sicheng Song, Yipeng Zhang, Yanna Lin, Huamin Qu, Changbo Wang, and Chen- hui Li. 2025. GVVST: Image-Driven Style Extraction From Graph Visualizations for Visual Style Transfer.IEEE Transactions on Visualization and Computer Graph- ics31, 9 (2025), 5975–5989. doi:10.1109/TVCG....
2025
-
[48]
Stokes, Kevin Yang, Kyle Swanson, Wengong Jin, Andres Cubillos- Ruiz, Nina M
Jonathan M. Stokes, Kevin Yang, Kyle Swanson, Wengong Jin, Andres Cubillos- Ruiz, Nina M. Donghia, Craig R. MacNair, Shawn French, Lindsey A. Carfrae, Zohar Bloom-Ackermann, Victoria M. Tran, Anush Chiappino-Pepe, Ahmed H. Badran, Ian W. Andrews, Emma J. Chory, George M. Churc...
2020 doi
-
[49]
Yushi Sun, Kai Sun, Yifan Ethan Xu, Xiao Yang, Xin Luna Dong, Nan Tang, and Lei Chen. 2025. KERAG: Knowledge-Enhanced Retrieval-Augmented Generation for Advanced Question Answering. InFindings of the Association for Computational Linguistics: EMNLP 2025. Association for Comput...
2025 doi
-
[50]
Siraki, and Khaled Barakat
Yasser Tabana, Dinesh Babu, Richard Fahlman, Arno G. Siraki, and Khaled Barakat
-
[51]
Daniel F Veber, Stephen R Johnson, Hung-Yuan Cheng, Brian R Smith, Keith W Ward, and Kenneth D Kopple. 2002. Molecular Properties that Influence the Oral Bioavailability of Drug Candidates.Journal of medicinal chemistry45, 12 (2002), 2615–2623. doi:10.1021/jm020017n
2002 doi
-
[52]
Waring, John Arrowsmith, Andrew R
Michael J. Waring, John Arrowsmith, Andrew R. Leach, Paul D. Leeson, Sam Mandrell, Robert M. Owen, Garry Pairaudeau, William D. Pennie, Stephen D. Pickett, Jibo Wang, Owen Wallace, and Alex Weir. 2015. An Analysis of the Attrition of Drug Candidates from Four Major Pharmaceuti...
2015 doi
-
[53]
Tongshuang Wu, Michael Terry, and Carrie Jun Cai. 2022. AI Chains: Transparent and Controllable Human-AI Interaction by Chaining Large Language Model Prompts. InProceedings of the 2022 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery, N...
2022
-
[54]
Zhenqin Wu, Bharath Ramsundar, Evan N Feinberg, Joseph Gomes, Caleb Ge- niesse, Aneesh Pappu, Karl Leswing, and Vijay Pande. 2018. MoleculeNet: A Benchmark for Molecular Machine Learning.Chemical Science9 (2018), 513–530. doi:10.1039/C7SC02664A
2018 doi
-
[55]
Guoli Xiong, Zhenxing Wu, Jiacai Yi, Li Fu, Zhijiang Yang, Changyu Hsieh, Mingzhu Yin, Xiangxiang Zeng, Chengkun Wu, Aiping Lu, et al. 2021. ADMETlab 2.0: An Integrated Online Platform for Accurate and Comprehensive Predictions of ADMET Properties.Nucleic acids research49, W1 ...
2021
-
[56]
Xiao Yang, Kai Sun, Hao Xin, Yushi Sun, Nikita Bhalla, Xiangsen Chen, Sajal Choudhary, Rongze Daniel Gui, Ziran Will Jiang, Ziyu Jiang, Lingkun Kong, Brian Moran, Jiaqi Wang, Yifan Ethan Xu, An Yan, Chenyu Yang, Eting Yuan, Hanwen Zha, Nan Tang, Lei Chen, Nicolas Scheffer, Yue...
2024
-
[57]
Zamfirescu-Pereira, Richmond Y
J.D. Zamfirescu-Pereira, Richmond Y. Wong, Bjoern Hartmann, and Qian Yang
-
[58]
Odin Zhang, Haitao Lin, Hui Zhang, Huifeng Zhao, Yufei Huang, Chang-Yu Hsieh, Peichen Pan, and Tingjun Hou. 2024. Deep Lead Optimization: Leveraging Generative AI for Structural Modification.Journal of the American Chemical Society146, 46 (2024), 31357–31370. doi:10.1021/jacs.4c11686
2024 doi
-
[59]
Yang Zhang, Jie Li, and Xu Chao. 2024. ChemNav: An Interactive Visual Tool to Navigate in the Latent Space for Chemical Molecules Discovery.Visual Informatics 8, 4 (2024), 60–70. doi:10.1016/j.visinf.2024.10.002
2024 doi
-
[60]
Wanjie Zheng, Jie Li, and Yang Zhang. 2023. Desirable Molecule Discovery via Generative Latent Space Exploration.Visual Informatics7, 4 (2023), 13–21. doi:10.1016/j.visinf.2023.10.002
2023 doi
-
[61]
Kaijie Zhu, Qinlin Zhao, Hao Chen, Jindong Wang, and Xing Xie. 2024. Prompt- Bench: A Unified Library for Evaluation of Large Language Models.Journal of Machine Learning Research25, 254 (2024), 1–22. https://arxiv.org/abs/2312.07910
2024 arXiv
-
[62]
InProceedings of the 2023 CHI Conference on Human Factors in Computing Systems
Why Johnny Can’t Prompt: How Non-AI Experts Try (and Fail) to Design LLM Prompts. InProceedings of the 2023 CHI Conference on Human Factors in Computing Systems. Association for Computing Machinery, New York, NY, USA, Article 437, 21 pages. doi:10.1145/3544548.3581388
2023
-
[2012]
doi:10.1016/j.addr.2012.09.019
Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings.Advanced drug delivery reviews64 (2012), 4–17. doi:10.1016/j.addr.2012.09.019
2012 doi
-
[2023]
doi:10.1186/ s12896-023-00815-4
Target Identification of Small Molecules: An Overview of the Current Applications in Drug Discovery.BMC Biotechnology23, 1 (2023), 44. doi:10.1186/ s12896-023-00815-4
2023
-
[2024]
InProceedings of the 2024 CHI Conference on Human Factors in Computing Systems (CHI ’24)
CreativeConnect: Supporting Reference Recombination for Graphic Design Ideation with Generative AI. InProceedings of the 2024 CHI Conference on Human Factors in Computing Systems (CHI ’24). Association for Computing Machinery, New York, NY, USA, Article 1055, 25 pages. doi:10....
2024
-
[2025]
doi:10.1021/acs.jcim.5c00641
Generative Deep Learning for de Novo Drug Design-A Chemical Space Odyssey.Journal of Chemical Information and Modeling65, 14 (2025), 7352–7372. doi:10.1021/acs.jcim.5c00641
2025 doi
Reviewed August 5, 2026 · model on record in the stance chip above.
Discussion (0). Sign in to comment.